Triptorelin
Also known as: trelstar, decapeptyl, D-Trp6-LHRH, triptorelin acetate, Decapeptyl research
GnRH agonist used clinically for prostate cancer and studied for HPT axis restoration post-steroid use.
Quick Reference
Triptorelin - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
GnRH-agonist
Triptorelin, sold under the brand name Decapeptyl among others, is a medication that acts as an agonist analog of gonadotropin-releasing hormone, repressing expression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It was patented in 1975 and approved for medical use in 1986. Triptorelin is a therapeutic alternative on the World Health Organization's List of Essential Medicines.
Mechanism of Action
Triptorelin, sold under the brand name Decapeptyl among others, is a medication that acts as an agonist analog of gonadotropin-releasing hormone, repressing expression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It was patented in 1975 and approved for medical use in 1986. Triptorelin is a therapeutic alternative on the World Health Organization's List of Essential Medicines.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
Triptorelin (also known as trelstar, decapeptyl) is studied within the sexual health and hormonal research community. GnRH agonist used clinically for prostate cancer and studied for HPT axis restoration post-steroid use.
Last updated October 28, 2026
Research status: active. Triptorelin appears across sexual health and hormonal research forums and academic literature. Researchers note this compound falls in the sexual health category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with Triptorelin. Comments are reviewed before appearing.